recordati rare diseases uk limited

5

recordati rare diseases uk limited Company Information

Share RECORDATI RARE DISEASES UK LIMITED
Live 
MatureMidLow

Company Number

03216698

Website

-

Registered Address

greengarth thicket grove, maidenhead, berkshire, SL6 4LW

Industry

Wholesale of pharmaceutical goods

 

Telephone

-

Next Accounts Due

September 2024

Group Structure

View All

Directors

Luigi Longinotti0 Years

Shareholders

recordati rare diseases sarl 100%

recordati rare diseases uk limited Estimated Valuation

£7.2m

Pomanda estimates the enterprise value of RECORDATI RARE DISEASES UK LIMITED at £7.2m based on a Turnover of £6.1m and 1.18x industry multiple (adjusted for size and gross margin).

recordati rare diseases uk limited Estimated Valuation

£13.9m

Pomanda estimates the enterprise value of RECORDATI RARE DISEASES UK LIMITED at £13.9m based on an EBITDA of £1.5m and a 9.23x industry multiple (adjusted for size and gross margin).

recordati rare diseases uk limited Estimated Valuation

£11m

Pomanda estimates the enterprise value of RECORDATI RARE DISEASES UK LIMITED at £11m based on Net Assets of £5.2m and 2.11x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Recordati Rare Diseases Uk Limited Overview

Recordati Rare Diseases Uk Limited is a live company located in berkshire, SL6 4LW with a Companies House number of 03216698. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in June 1996, it's largest shareholder is recordati rare diseases sarl with a 100% stake. Recordati Rare Diseases Uk Limited is a mature, mid sized company, Pomanda has estimated its turnover at £6.1m with low growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Recordati Rare Diseases Uk Limited Health Check

Pomanda's financial health check has awarded Recordati Rare Diseases Uk Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

6 Strong

positive_score

1 Regular

positive_score

5 Weak

size

Size

annual sales of £6.1m, make it smaller than the average company (£25.8m)

£6.1m - Recordati Rare Diseases Uk Limited

£25.8m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (4.4%)

2% - Recordati Rare Diseases Uk Limited

4.4% - Industry AVG

production

Production

with a gross margin of 59%, this company has a lower cost of product (26.3%)

59% - Recordati Rare Diseases Uk Limited

26.3% - Industry AVG

profitability

Profitability

an operating margin of 24.3% make it more profitable than the average company (4%)

24.3% - Recordati Rare Diseases Uk Limited

4% - Industry AVG

employees

Employees

with 8 employees, this is below the industry average (38)

8 - Recordati Rare Diseases Uk Limited

38 - Industry AVG

paystructure

Pay Structure

on an average salary of £104.3k, the company has a higher pay structure (£72.2k)

£104.3k - Recordati Rare Diseases Uk Limited

£72.2k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £761.1k, this is more efficient (£627.3k)

£761.1k - Recordati Rare Diseases Uk Limited

£627.3k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 70 days, this is near the average (59 days)

70 days - Recordati Rare Diseases Uk Limited

59 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 13 days, this is quicker than average (29 days)

13 days - Recordati Rare Diseases Uk Limited

29 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 30 days, this is less than average (66 days)

30 days - Recordati Rare Diseases Uk Limited

66 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 129 weeks, this is more cash available to meet short term requirements (12 weeks)

129 weeks - Recordati Rare Diseases Uk Limited

12 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 32%, this is a lower level of debt than the average (56.5%)

32% - Recordati Rare Diseases Uk Limited

56.5% - Industry AVG

RECORDATI RARE DISEASES UK LIMITED financials

EXPORTms excel logo

Recordati Rare Diseases Uk Limited's latest turnover from December 2022 is £6.1 million and the company has net assets of £5.2 million. According to their latest financial statements, Recordati Rare Diseases Uk Limited has 8 employees and maintains cash reserves of £6.1 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover6,088,5925,932,8736,061,1155,725,2275,622,3535,074,3904,891,4214,171,5563,447,2984,277,9744,464,8294,134,7833,929,6250
Other Income Or Grants00000000000000
Cost Of Sales2,499,1572,215,2882,151,4641,996,6972,019,7312,195,8482,081,5341,666,0691,545,8871,827,7341,796,1561,995,5602,305,4840
Gross Profit3,589,4353,717,5853,909,6513,728,5303,602,6222,878,5422,809,8872,505,4871,901,4112,450,2402,668,6732,139,2231,624,1410
Admin Expenses2,112,6241,737,4621,343,0521,045,7211,085,898895,779815,520812,817917,474816,954797,192852,118793,352-978,939
Operating Profit1,476,8111,980,1232,566,5992,682,8092,516,7241,982,7631,994,3671,692,670983,9371,633,2861,871,4811,287,105830,789978,939
Interest Payable0052,628000006,3584,7210000
Interest Receivable0263,9545,865003,3617,4839,91327,6736,04010,0685,014629
Pre-Tax Profit1,476,8111,980,1492,517,9252,688,6742,519,9291,984,8291,997,7281,700,153987,4921,656,2381,877,5211,297,173835,803979,568
Tax-185,016-376,761-474,757-502,277-439,520-374,841-384,327-344,921-213,292-385,597-462,142-356,767-169,582-274,279
Profit After Tax1,291,7951,603,3882,043,1682,186,3972,080,4091,609,9881,613,4011,355,232774,2001,270,6411,415,379940,406666,221705,289
Dividends Paid002,100,0002,000,0002,000,0002,000,0001,350,000750,0001,200,0001,000,0002,000,000000
Retained Profit1,291,7951,603,388-56,832186,39780,409-390,012263,401605,232-425,800270,641-584,621940,406666,221705,289
Employee Costs834,384546,704749,982475,373405,748526,050462,062513,842591,625490,278521,533580,140533,1010
Number Of Employees8666655689910100
EBITDA*1,511,1622,012,4412,598,5562,686,2792,524,6021,990,7282,000,7361,694,383986,3951,636,5161,875,3041,293,046837,063984,189

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets7,77437,69460,6595,4214,1588,66115,8623,2943,7554,2544,6886,37512,31716,168
Intangible Assets827961,5751,3624259951,7590000000
Investments & Other00000000000000
Debtors (Due After 1 year)00000000000000
Total Fixed Assets7,85638,49062,2346,7834,5839,65617,6213,2943,7554,2544,6886,37512,31716,168
Stock & work in progress208,783552,116503,16100002,4674,6655,6862,3124,8703,5007,028
Trade Debtors1,174,5001,093,951727,145886,985808,622675,771694,587555,178397,180611,094793,522535,290574,2311,484,377
Group Debtors98,044109,51000001,93343,145981,9261,247,0371,005,324795,968809,9920
Misc Debtors78,844474,302720,220234,96242,71343,11738,60636,22630,11831,97822,75021,62231,0850
Cash6,087,0583,964,8772,581,5782,510,4072,055,5722,124,6562,543,3012,244,000659,722875,828801,0981,717,529460,265251,666
misc current assets00000000000000
total current assets7,647,2296,194,7564,532,1043,632,3542,906,9072,843,5443,278,4272,881,0162,073,6112,771,6232,625,0063,075,2791,879,0731,743,071
total assets7,655,0856,233,2464,594,3383,639,1372,911,4902,853,2003,296,0482,884,3102,077,3662,775,8772,629,6943,081,6541,891,3901,759,239
Bank overdraft000000009,24500000
Bank loan00000000000000
Trade Creditors 93,14136,6232,86028,91529,33620,13417,12832,8705,18421,1373,02013,1539,6301,003,950
Group/Directors Accounts1,064,037882,6941,097,295720,183277,990221,752334,152293,698118,629267,80657,27474,83847,9600
other short term finances00000000000000
hp & lease commitments00000000000000
other current liabilities1,291,9931,399,8101,179,368522,476422,998510,557453,999330,374322,172438,998792,105631,747412,2900
total current liabilities2,449,1712,319,1272,279,5231,271,574730,324752,443805,279656,942455,230727,941852,399719,738469,8801,003,950
loans00000000000000
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities00000000000000
provisions004,08400000000000
total long term liabilities004,08400000000000
total liabilities2,449,1712,319,1272,283,6071,271,574730,324752,443805,279656,942455,230727,941852,399719,738469,8801,003,950
net assets5,205,9143,914,1192,310,7312,367,5632,181,1662,100,7572,490,7692,227,3681,622,1362,047,9361,777,2952,361,9161,421,510755,289
total shareholders funds5,205,9143,914,1192,310,7312,367,5632,181,1662,100,7572,490,7692,227,3681,622,1362,047,9361,777,2952,361,9161,421,510755,289
Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit1,476,8111,980,1232,566,5992,682,8092,516,7241,982,7631,994,3671,692,670983,9371,633,2861,871,4811,287,105830,789978,939
Depreciation33,63731,53931,1633,0767,0177,2015,8381,7132,4583,2303,8235,9416,2745,250
Amortisation7147797943948617645310000000
Tax-185,016-376,761-474,757-502,277-439,520-374,841-384,327-344,921-213,292-385,597-462,142-356,767-169,582-274,279
Stock-343,33348,955503,161000-2,467-2,198-1,0213,374-2,5581,370-3,5287,028
Debtors-326,375230,398325,418270,612132,447-16,238100,577-774,675-480,88568,513468,716-62,428-69,0691,484,377
Creditors56,51833,763-26,055-4219,2023,006-15,74227,686-15,95318,117-10,1333,523-994,3201,003,950
Accruals and Deferred Income-107,817220,442656,89299,478-87,55956,558123,6258,202-116,826-353,107160,358219,457412,2900
Deferred Taxes & Provisions0-4,0844,08400000000000
Cash flow from operations1,944,5551,606,4481,930,1412,012,4471,874,2781,691,6891,626,1822,162,2231,122,230844,0421,097,2291,220,317158,048222,455
Investing Activities
capital expenditure-3,717-8,574-87,408-5,670-2,8050-20,696-1,252-1,959-2,796-2,1361-2,423-21,418
Change in Investments00000000000000
cash flow from investments-3,717-8,574-87,408-5,670-2,8050-20,696-1,252-1,959-2,796-2,1361-2,423-21,418
Financing Activities
Bank loans00000000000000
Group/Directors Accounts181,343-214,601377,112442,19356,238-112,40040,454175,069-149,177210,532-17,56426,87847,9600
Other Short Term Loans 00000000000000
Long term loans00000000000000
Hire Purchase and Lease Commitments00000000000000
other long term liabilities00000000000000
share issue000000000000050,000
interest026-48,6745,865003,3617,4833,55522,9526,04010,0685,014629
cash flow from financing181,343-214,575328,438448,05856,238-112,40043,815182,552-145,622233,484-11,52436,94652,97450,629
cash and cash equivalents
cash2,122,1811,383,29971,171454,835-69,084-418,645299,3011,584,278-216,10674,730-916,4311,257,264208,599251,666
overdraft0000000-9,2459,24500000
change in cash2,122,1811,383,29971,171454,835-69,084-418,645299,3011,593,523-225,35174,730-916,4311,257,264208,599251,666

recordati rare diseases uk limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for recordati rare diseases uk limited. Get real-time insights into recordati rare diseases uk limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Recordati Rare Diseases Uk Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for recordati rare diseases uk limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

recordati rare diseases uk limited Ownership

RECORDATI RARE DISEASES UK LIMITED group structure

Recordati Rare Diseases Uk Limited has no subsidiary companies.

Ultimate parent company

RECORDATI IND. CHEM. E FARMACEUTICA SPA

#0066626

SELVI SPA

#0025424

2 parents

RECORDATI RARE DISEASES UK LIMITED

03216698

RECORDATI RARE DISEASES UK LIMITED Shareholders

recordati rare diseases sarl 100%

recordati rare diseases uk limited directors

Recordati Rare Diseases Uk Limited currently has 1 director, Mr Luigi Longinotti serving since Sep 2023.

officercountryagestartendrole
Mr Luigi LonginottiEngland49 years Sep 2023- Director

P&L

December 2022

turnover

6.1m

+3%

operating profit

1.5m

-25%

gross margin

59%

-5.92%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2022

net assets

5.2m

+0.33%

total assets

7.7m

+0.23%

cash

6.1m

+0.54%

net assets

Total assets minus all liabilities

recordati rare diseases uk limited company details

company number

03216698

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

June 1996

age

28

accounts

Small Company

ultimate parent company

RECORDATI IND. CHEM. E FARMACEUTICA SPA

previous names

orphan europe (uk) limited (April 2019)

incorporated

UK

address

greengarth thicket grove, maidenhead, berkshire, SL6 4LW

last accounts submitted

December 2022

recordati rare diseases uk limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to recordati rare diseases uk limited.

charges

recordati rare diseases uk limited Companies House Filings - See Documents

datedescriptionview/download